Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation

Molecular Cell

Volumn 17, Issue 3, 2005, Pages 351-365

  Bennett, Eric J ^a   Bence, Neil F ^a   Jayakumar, Rajadas ^a,b   Kopito, Ron R ^a  

^a STANFORD UNIVERSITY   (United States)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; NUCLEAR PROTEIN; PROTEASOME; UBIQUITIN;

ARTICLE; CELL COMPARTMENTALIZATION; CELL INCLUSION; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING;

CELL LINE; CYTOPLASM; GREEN FLUORESCENT PROTEINS; HUMANS; INCLUSION BODIES; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT FUSION PROTEINS; RHODOPSIN; TRANSFECTION; UBIQUITIN;

EID: 13244258435     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.12.021     Document Type: Article

References (56)

1. Akopian T.N., Kisselev A.F., Goldberg A.L. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem. 272:1997;1791-1798
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 431:2004;805-810
3. Baek S.H., Choi K.S., Yoo Y.J., Cho J.M., Baker R.T., Tanaka K., Chung C.H. Molecular cloning of a novel ubiquitin-specific protease, UBP41, with isopeptidase activity in chick skeletal muscle. J. Biol. Chem. 272:1997;25560-25565
4. Bence N., Sampat R., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 292:2001;1552-1555
5. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:2002;507-511
6. Chen J., Fang G. MAD2B is an inhibitor of the anaphase-promoting complex. Genes Dev. 15:2001;1765-1770
7. Chen S., Wetzel R. Solubilization and disaggregation of polyglutamine peptides. Protein Sci. 10:2001;887-891
8. Chen S., Berthelier V., Yang W., Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311:2001;173-182
9. Coffino P. Regulation of cellular polyamines by antizyme. Nat. Rev. Mol. Cell Biol. 2:2001;188-194
10. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19:1998;148-154
11. Cummings C.J., Orr H.T., Zoghbi H.Y. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1999;1079-1081. a
12. Cummings C.J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H.T., Beaudet A.L., Zoghbi H.Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron. 24:1999;879-892. b
13. Donaldson K.M., Li W., Ching K.A., Batalov S., Tsai C.C., Joazeiro C.A. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc. Natl. Acad. Sci. USA. 100:2003;8892-8897
14. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 408:2000;101-106
15. Fink A.L. Protein aggregation. folding aggregates, inclusion bodies and amyloid Fold. Des. 3:1998;R9-R23
16. Fischer U., Huber J., Boelens W.C., Mattaj I.W., Lührmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483
17. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron. 40:2003;25-40
18. Hackam A.S., Singaraja R., Zhang T., Gan L., Hayden M.R. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hum. Mol. Genet. 8:1999;25-33
19. He L., Lu X.Y., Jolly A.F., Eldridge A.G., Watson S.J., Jackson P.K., Barsh G.S., Gunn T.M. Spongiform degeneration in mahoganoid mutant mice. Science. 299:2003;710-712
20. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479
21. Holmberg C.I., Staniszewski K.E., Mensah K.N., Matouschek A., Morimoto R.I. Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J. 23:2004;4307-4318
22. Illing M.E., Rajan R.S., Bence N.F., Kopito R.R. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277:2002;34150-34160
23. Jana N.R., Zemskov E.A., Wang G., Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10:2001;1049-1059
24. Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:2000;12571-12576
25. Kalderon D., Richardson W.D., Markham A.F., Smith A.E. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature. 311:1984;33-38
26. Kawaguchi Y., Kovacs J.J., McLaurin A., Vance J.M., Ito A., Yao T.P. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 115:2003;727-738
27. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489
28. Kazantsev A., Preisinger E., Dranovsky A., Goldgaber D., Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. USA. 96:1999;11404-11409
29. Kim S., Nollen E.A., Kitagawa K., Bindokas V.P., Morimoto R.I. Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4:2002;826-831
30. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., Orr H.T. Ataxin-1 nuclear localization and aggregation. role in polyglutamine-induced disease in SCA1 transgenic mice Cell. 95:1998;41-53
31. Koo E.H., Lansbury P.T. Jr., Kelly J.W. Amyloid diseases. abnormal protein aggregation in neurodegeneration Proc. Natl. Acad. Sci. USA. 96:1999;9989-9990
32. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10:2000;524-530
33. Lashuel H.A., Hartley D., Petre B.M., Walz T., Lansbury P.T. Jr. Neurodegenerative disease. amyloid pores from pathogenic mutations Nature. 418:2002;291
34. Mizuno Y., Hattori N., Mori H., Suzuki T., Tanaka K. Parkin and Parkinson's disease. Curr. Opin. Neurol. 14:2001;477-482
35. Nucifora F.C. Jr., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 291:2001;2423-2428
36. Perutz M.F., Johnson T., Suzuki M., Finch J.T. Glutamine repeats as polar zippers. their possible role in inherited neurodegenerative diseases Proc. Natl. Acad. Sci. USA. 91:1994;5355-5358
37. Peters M.F., Nucifora F.C. Jr., Kushi J., Seaman H.C., Cooper J.K., Herring W.J., Dawson V.L., Dawson T.M., Ross C.A. Nuclear targeting of mutant Huntingtin increases toxicity. Mol. Cell. Neurosci. 14:1999;121-128
38. Poirier M.A., Li H., Macosko J., Cai S., Amzel M., Ross C.A. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem. 277:2002;41032-41037
39. Reits E.A., Benham A.M., Plougastel B., Neefjes J., Trowsdale J. Dynamics of proteasome distribution in living cells. EMBO J. 16:1997;6087-6094
40. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23:1999;47-51
41. Saliba R.S., Munro P.M., Luthert P.J., Cheetham M.E. The cellular fate of mutant rhodopsin. quality control, degradation and aggresome formation J. Cell Sci. 115:2002;2907-2918
42. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66
43. Schaffar G., Breuer P., Boteva R., Behrends C., Tzvetkov N., Strippel N., Sakahira H., Siegers K., Hayer-Hartl M., Hartl F.U. Cellular toxicity of polyglutamine expansion proteins; mechanism of transcription factor deactivation. Mol. Cell. 15:2004;95-105
44. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., Bates G.P., Lehrach H., Wanker E.E. Self-assembly of polyglutamine- containing huntingtin fragments into amyloid-like fibrils. implications for Huntington's disease pathology Proc. Natl. Acad. Sci. USA. 96:1999;4604-4609
45. Schmidt T., Lindenberg K.S., Krebs A., Schols L., Laccone F., Herms J., Rechsteiner M., Riess O., Landwehrmeyer G.B. Protein surveillance machinery in brains with spinocerebellar ataxia type 3. redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions Ann. Neurol. 51:2002;302-310
46. Stenoien D.L., Mielke M., Mancini M.A. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat. Cell Biol. 4:2002;806-810
47. Sun X.M., Butterworth M., MacFarlane M., Dubiel W., Ciechanover A., Cohen G.M. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell. 14:2004;81-93
48. Sung C.H., Davenport C.M., Nathans J. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J. Biol. Chem. 268:1993;26645-26649
49. Taylor J.P., Hardy J., Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science. 296:2002;1991-1995
50. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., Fischbeck K.H. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12:2003;749-757
51. Temussi P.A., Masino L., Pastore A. From Alzheimer to Huntington. why is a structural understanding so difficult? EMBO J. 22:2003;355-361
52. Tran P.B., Miller R.J. Aggregates in neurodegenerative disease. crowds and power? Trends Neurosci. 22:1999;194-197
53. Venkatraman P., Wetzel R., Tanaka M., Nukina N., Goldberg A.L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell. 14:2004;95-104
54. Verhoef L.G., Lindsten K., Masucci M.G., Dantuma N.P. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 11:2002;2689-2700
55. Wanker E.E. Protein aggregation and pathogenesis of Huntington's disease. mechanisms and correlations Biol. Chem. 381:2000;937-942
56. Wanker E.E., Scherzinger E., Heiser V., Sittler A., Eickhoff H., Lehrach H. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309:1999;375-386